Malignant pleural mesothelioma characteristics and outcomes: A SEER‐Medicare analysis
Journal of Surgical Oncology · 2023
DOI: 10.1002/jso.27243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2023. Verfasst von Emanuela Taioli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA. Hauptthemen laut MEDLINE: Mesothelioma, Malignant, Mesothelioma, Pleural Neoplasms, Lung Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Background
Pleural mesothelioma is rare cancer linked to asbestos exposure. Previous research has indicated that female individuals have better survival than male individuals, but this has never been examined in the Surveillance, Epidemiology, and End Results (SEER)‐Medicare database. Materials and Methods Malignant pleural mesothelioma cases diagnosed from 1992 to 2015 were queried from the linked SEER‐Medicare database. Multivariable logistic regression was used to assess the clinical and demographic factors associated with sex. A multivariable Cox proportional hazards model and propensity matching methods were used to assess sex differences in overall survival (OS) while accounting for potential confounders.
Results
Among 4201 patients included in the analysis, 3340 (79.5%) were males and 861 (20.5%) females. Females were significantly older, with more epithelial histology than males were, and had significantly better OS, adjusted for confounders (adjusted hazard ratio, 0.83, 95% confidence interval: 0.76–0.90). Other variables independently associated with improved survival included younger age at diagnosis, having a spouse/domestic partner, epithelial histology, lower comorbidity score, and receipt of surgery or chemotherapy.
Conclusions
The study describes sex differences in mesothelioma occurrence, treatment, and survival and is the first to examine SEER‐Medicare. It provides directions for future research into potential therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
- Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
ORCID-Profile: Emanuela Taioli
Zitieren
APA
Taioli, E., Wolf, A., Alpert, N., Rosenthal, D., & Flores, R. (2023). Malignant pleural mesothelioma characteristics and outcomes: A SEER‐Medicare analysis. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27243
Vancouver
Taioli E, Wolf A, Alpert N, Rosenthal D, Flores R. Malignant pleural mesothelioma characteristics and outcomes: A SEER‐Medicare analysis. Journal of Surgical Oncology. 2023. doi:10.1002/jso.27243
BibTeX
@article{Taioli2023,
author = {Taioli, Emanuela and Wolf, Andrea and Alpert, Naomi and Rosenthal, Daniel and Flores, Raja},
title = {Malignant pleural mesothelioma characteristics and outcomes: A SEER‐Medicare analysis},
journal = {Journal of Surgical Oncology},
year = {2023},
doi = {10.1002/jso.27243}
}
EUVIMED